Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Alendronate Sodium and Vitamin D3 Tablets

Approved

化学药品

Alendronate Sodium and Vitamin D3 Tablets

Organon NV🇨🇳 National Medical Products Administration

Approval Date: Jul 24, 2023
Approval ID: 8VIZRny3LDp
Company: Organon NV
Type: 化学药品

Approval Details

Approval Id: 8VIZRny3LDp
Approval Number: 国药准字HJ20150109
Generic Name: 阿仑膦酸钠维D3片(Ⅱ)
Generic Name En: Alendronate Sodium and Vitamin D3 Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含阿仑膦酸钠70mg（以阿仑膦酸计）和维生素D3 5600IU（相当于140μg）
Reg Date: 2023-07-24
Expired Date: 2028-07-23
Company Name: Organon NV
Company Detail Path: /organization/organon-nv

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 24, 2023

Approval ID

8VIZRny3LDp

Type

化学药品

Back to NMPA Approvals

阿仑膦酸钠维D3片(Ⅱ) - NMPA Drug Approval Details